Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “California”

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung CancerRecruiting
NCT07365241Phase 3Updated Aug 21, 2026
Sponsor: AbbVie
Small Cell Lung Cancer
United States, Austria, Germany, Greece, Japan +2 more
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLRecruiting
NCT07007312Phase 3Updated Aug 20, 2026
Sponsor: Kura Oncology, Inc.
Acute Myeloid Leukemia (AML)
United States, Australia, Belgium, Canada, Czechia +11 more
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting
NCT07184996Phase 3Updated Aug 20, 2026
Sponsor: Sanofi
Ulcerative Colitis
United States, Bulgaria, Canada, China, Czechia +15 more
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck CancerSuspended
NCT01810913Phase 2, Phase 3Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma · Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 · Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 · Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
United States, Canada, Hong Kong
A Study to Test Whether Nerandomilast Helps People With Systemic SclerosisRecruiting
NCT07497087Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Systemic Sclerosis
United States, Argentina, Australia, Austria, Belgium +40 more
A Study of JADE101 in Participants With Immunoglobulin A NephropathyRecruiting
NCT07541287Phase 2Updated Aug 20, 2026
Sponsor: Jade Biosciences, Inc.
IgA Nephropathy
United States, Australia, New Zealand, South Korea, Taiwan
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation RetinopathyRecruiting
NCT05844982Phase 3Updated Aug 20, 2026
Sponsor: Jaeb Center for Health Research
Radiation Retinopathy · Visual Impairment
United States
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune SystemRecruiting
NCT07042295Phase 2Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Locally Recurrent Skin Squamous Cell Carcinoma · Metastatic Skin Squamous Cell Carcinoma
United States
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and ProteinuriaRecruiting
NCT05457283Phase 3Updated Aug 20, 2026
Sponsor: Bayer
Chronic Kidney Disease · Proteinuria · Children
United States, Argentina, Australia, Austria, Belgium +27 more
Prophylactic Reinforcement of Ventral Abdominal Incisions TrialActive Not Recruiting
NCT03911700NAUpdated Aug 20, 2026
Sponsor: C. R. Bard
Open Midline Laparotomy
United States, Austria, Belgium, France, Germany
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical CancersRecruiting
NCT06538337NAUpdated Aug 20, 2026
Sponsor: Jonsson Comprehensive Cancer Center
Endometrial Cancer · Cervical Cancer
United States
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus ErythematosusActive Not Recruiting
NCT05531565Phase 2, Phase 3Updated Aug 20, 2026
Sponsor: Biogen
Subacute Cutaneous Lupus Erythematosus · Chronic Cutaneous Lupus Erythematosus
United States, Argentina, Belgium, Brazil, Bulgaria +25 more
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With AcromegalyCompleted
NCT04076462Phase 3Updated Aug 20, 2026
Sponsor: Camurus AB
Acromegaly
United States, Germany, Greece, Hungary, Italy +5 more
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal CancerRecruiting
NCT07446322Phase 2Updated Aug 20, 2026
Sponsor: Oncolytics Biotech
Ras-mutated Metastatic Colorectal Cancer · mCRC · MSS Metastatic Colorectal Cancer
United States
A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This MedicineActive Not Recruiting
NCT06619509Phase 2Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Solid Tumours
United States, Argentina, Australia, Belgium, Canada +15 more
Hand Rehabilitation Study for Stroke PatientsTerminated
NCT03148106NAUpdated Aug 20, 2026
Sponsor: University of California, San Francisco
Upper Extremity Paresis · Disability Physical · Chronic Stroke · Motor Disorders
United States
Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer SurvivorsActive Not Recruiting
NCT01450020NAUpdated Aug 20, 2026
Sponsor: City of Hope Medical Center
Breast Cancer
United States
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2Recruiting
NCT07227246Phase 3Updated Aug 20, 2026
Sponsor: Joseph Broderick, MD
Intracerebral Hemorrhage
United States, Canada, Germany, Japan, Spain +1 more
Pembrolizumab in Treating Participants With LeukoplakiaRecruiting
NCT03603223Phase 2Updated Aug 20, 2026
Sponsor: Jonsson Comprehensive Cancer Center
Erythroleukoplakia · Leukoplakia · Verrucous Oral Leukoplakia
United States
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerActive Not Recruiting
NCT04487080Phase 3Updated Aug 20, 2026
Sponsor: Janssen Research & Development, LLC
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Belgium, Brazil +23 more
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic RetinopathyActive Not Recruiting
NCT06321302Phase 2Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Diabetic Retinopathy
United States, Germany, Hungary, Italy, Japan +4 more
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast CancerActive Not Recruiting
NCT05870579Phase 1Updated Aug 20, 2026
Sponsor: Novartis Pharmaceuticals
Breast Cancer
United States, China, France, Germany, Poland +2 more
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)Active Not Recruiting
NCT04008030Phase 3Updated Aug 20, 2026
Sponsor: Bristol-Myers Squibb
Metastatic Colorectal Cancer
United States, Argentina, Australia, Austria, Belgium +19 more
Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing PancreatectomyNot Yet Recruiting
NCT07608458NAUpdated Aug 20, 2026
Sponsor: City of Hope Medical Center
Hepatocellular Carcinoma · Pancreas Cancer · Biliary Tract Neoplasms
United States
A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)Active Not Recruiting
NCT06185764Phase 1, Phase 2Updated Aug 20, 2026
Sponsor: Vertex Pharmaceuticals Incorporated
Myotonic Dystrophy Type 1 (DM1)
United States, Australia, Belgium, Canada, France +5 more

Previous page Next page